相关实验视频

Updated: May 10, 2025

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

乙基基脂封装胰岛素样生长因子1受体siRNA用于肝细胞癌治疗

Yang Pu^1,2, Quanxin Wang¹, Yufei Pan¹

¹State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Molecular pharmaceutics

|April 28, 2025

概括

研究人员开发了携带小干扰RNA (siRNA) 的新型脂质复合体,以向肝癌中的胰岛素类生长因子1受体 (IGF1R). 这种向治疗显著抑制了肝细胞癌 (HCC) 的生长超过91%.

科学领域:

在瘤学瘤学.
纳米技术纳米技术
分子生物学分子生物学

背景情况:

肝细胞癌 (HCC) 是最常见的肝癌,缺乏有效的向治疗.
胰岛素类生长因子1受体 (IGF1R) 的过度表达驱动HCC的扩散和生存.
向IGF1R为HC提供了一个潜在的治疗策略.

研究的目的:

设计和开发针对IGF1RmRNA (siIGF1Rs) 的新型小干扰RNA (siRNAs).
创建稳定,向的脂质复合体 (siIGF1R/Mix/PEG) 以提高传递和疗效.
评估siIGF1R/Mix/PEG在HCC治疗中的治疗潜力.

主要方法:

针对IGF1R的siRNAs被化学修改以提高稳定性和性能.
脂质复合物 (siIGF1R/Mix/PEG) 是使用 DNCA,CLD 和 DSPE-PEG 进行的.
在体外和体内研究评估了细胞吸收,基因沉默,细胞循环,细胞亡和瘤抑制.

主要成果:

siIGF1R/Mix/PEG复合物有效地降低了HCC细胞中的IGF1RmRNA (>95%) 和前mRNA (>50%).
治疗诱导了S阶段细胞周期停止,并促进了HCC细胞的亡.
静脉注射siIGF1R/Mix/PEG (0.8 mg/kg) 显著抑制了91.31%的瘤生长,并选择性瘤积累.

结论:

在向脂质复合体中封装的化学修饰的siIGF1Rs显示出对HCC的强烈抗癌活性.
siIGF1R/Mix/PEG配方提供了一个有前途的向治疗,具有持续释放和长时间的效果.
这种方法为开发新型肝细胞癌治疗提供了可行的策略.

关键词:

阴阳性脂质阴阳性脂质赛蒂迪尼尔脂化物赛蒂迪尼尔脂化物肝细胞癌是肝细胞癌.胰岛素样生长因子1受体修改后的siRNA是什么意思

更多相关视频

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

相关概念视频

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...